FAT4 expression was significantly and negatively correlated with several immunoinhibitors in HCC, including LAG3, CTLA4, CD160, and PVRL2 (p < 0.05; Fig. 7a,b,c,d,e). The gene discussed is FAT4; the disease is hepatocellular carcinoma.